Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now

Search Results for "RMM":

Results: 23

Quotes

RMM RiverNorth Managed Duration Municipal Income Fund Inc Stock - NYSE equities RMMZ RiverNorth Managed Duration Municipal Income Fund II, Inc Stock - NYSE equities RESU Resurgere Mines & Minerals India Ltd Stock - NSE equities RMMC River and Mercantile UK Micro Cap Investment Company Ltd Stock - London equities RMMGX American Funds Short-term Bond Fund Of America® Class R-6 Fund - US Funds fund RMMBX Aspiriant Risk-managed Municipal Bond Fund Fund - US Funds fund 0P00000QAU Rmm Stratégie Diversifiée C Fund - Paris fund 0P00000QAV Rmm Top Management D Fund - Paris fund
Show all (11)

News

RiverNorth Closed-End Funds Declare Monthly Distributions
By Investing.com

WEST PALM BEACH, Fla.--(BUSINESS WIRE)--In accordance with the RiverNorth closed-end funds (the Funds) level distribution policies, the Funds have declared distributions for April, May and June...

N-able Builds on the Ecoverse Vision by adding Rewst and HaloPSA Integrations
By Investing.com

N-able showcases vision for the future that reduces complexities for MSPs and harmonizes modern IT BURLINGTON, Mass.--(BUSINESS WIRE)--(live from Empower, Frisco) “ N-able, Inc. (NYSE: NABL), a...

Earnings call: N-able reports strong Q4 performance in light of new product launches
By Investing.com

N-able, Inc. (NYSE: NABL) reported a robust financial performance for the fourth quarter and full year of 2023, with a strong focus on expanding its product offerings and customer base. The company...

Show all (5)

Analysis

Amgen's Multiple Myeloma Drug Receives NICE Recommendation
By Zacks Investment Research

Amgen Inc. (NASDAQ:CELG) Revlimid (lenalidomide) and dexamethasone, is already approved in the EU for the treatment of multiple myeloma in patients who have received at least one prior therapy....

Christopher Welch: Searching For A Perfect 10 In The Mining Space
By The Gold Report

Investors in the mining space are always on the lookout for a "perfect 10." Christopher Welch, a mining analyst with Ocean Equities in London, ranks jurisdictions and companies in this interview with...

Bristol-Myers Empliciti Combo Fails In First-Line Myeloma Study
By Zacks Investment Research

Bristol-Myers Squibb Company (NYSE:BMY) announced that a phase III ELOQUENT-1 study evaluating Empliciti (elotuzumab) triplet combination in first-line patients with multiple myeloma, who are...

Show all (7)
Results: 11

Refine Results

Instrument Type

Region

 

Country

Exchange

Sector

 

Industry

 
Results: 5

Refine Results

Date

Date
 

Category

Provider

 

News

{{title}}
By {{provider}}

{{content}}

Please try another search

Results: 7

Refine Results

Date

Date
 

Category

Author

Analysis

{{title}}
By {{provider}}

{{content}}

Results: 0

Refine Results

Country

Importance

Economic Events

Results: 0

Tools & Sections

Results: 0

Authors

Continue with Google
or
Sign up with Email